Jerry Cacia joined Link Cell Therapy in November 2023 as the Chief Operating Officer. In his prior role, Jerry served as the Chief Technical Officer at Graphite Bio. In this role, he built the CMC function that developed and delivered Graphite’s autologous gene-edited stem cell treatment for Sickle Cell disease to the clinic.
Prior to joining Graphite, Jerry was with Genentech and Roche for over 32 years. During his tenure, he held various senior leadership positions across the CMC disciplines, including technical development, manufacturing, and quality. In his most recent position, Jerry served as head of global technical development at Roche during which time he supported a pipeline that included over 80 new molecular entities across multiple modalities, and more than 100 projects in various stages of development.
Jerry holds a BA degree in Biological Sciences from the University of California at Santa Cruz.
